Envoy Medical, Inc. (NASDAQ:COCH – Get Free Report) was the recipient of a large increase in short interest in August. As of August 31st, there was short interest totalling 23,500 shares, an increase of 5.9% from the August 15th total of 22,200 shares. Based on an average daily volume of 22,000 shares, the short-interest ratio is presently 1.1 days. Currently, 0.4% of the shares of the company are short sold.
Envoy Medical Stock Performance
Shares of NASDAQ:COCH traded down $0.11 on Tuesday, reaching $3.21. 15,343 shares of the company’s stock were exchanged, compared to its average volume of 174,639. The company has a fifty day moving average of $2.65 and a 200-day moving average of $3.54. Envoy Medical has a twelve month low of $0.75 and a twelve month high of $11.72.
Envoy Medical (NASDAQ:COCH – Get Free Report) last posted its quarterly earnings results on Monday, August 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.03). The company had revenue of $0.07 million for the quarter, compared to analyst estimates of $0.08 million. Equities research analysts predict that Envoy Medical will post -1.36 earnings per share for the current year.
Institutional Trading of Envoy Medical
Wall Street Analyst Weigh In
Separately, Ascendiant Capital Markets increased their target price on shares of Envoy Medical from $8.50 to $8.75 and gave the stock a “buy” rating in a research report on Tuesday, September 3rd.
About Envoy Medical
Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.
See Also
- Five stocks we like better than Envoy Medical
- Profitably Trade Stocks at 52-Week Highs
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- How to Calculate Return on Investment (ROI)
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Consumer Discretionary Stocks Explained
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.